Equillium Inc stock is traded at $1.40, with a volume of 2,420. It is down -1.76% in the last 24 hours and down -7.00% over the past month. Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Previous Close:
$1.42
Open:
$1.40
24h Volume:
2,420
Relative Volume:
0.01
Market Cap:
$109.32M
Revenue:
$4.39M
Net Income/Loss:
-$22.40M
P/E Ratio:
-
EPS:
-$0.5098
Net Cash Flow:
-$22.79M
1W Performance:
+4.89%
1M Performance:
-7.00%
6M Performance:
-38.55%
1Y Performance:
+50.97%
1-Day Range:
$1.35$1.40
1-Week Range:
$1.33$1.61
52-Week Range:
$0.7562$3.54
Equillium Inc Stock (EQ) Company Profile
Name
Equillium IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 412-5302Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS